Tag: Uniqure NV UQ1-FF

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease